Mergenet Solutions, Inc. Issues Dividend

Friday, October 20, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

COCONUT CREEK, Fla., Oct. 20, 2017 /PRNewswire/ --Mergenet Solutions, Inc. of Coconut Creek, FL

has declared a cash dividend. Mergenet Solutions, Inc. was previously parent to Innomed Technologies, Inc. and Respcare, Inc.. Mergenet Solutions, Inc. is also parent to Mergenet Medical, Inc..

Innomed Technologies, Inc. and Respcare, Inc. were

recently acquired, allowing for the dividend to be paid to Mergenet Solutions, Inc. shareholders of record as of July 10, 2017.

Innomed Technologies, Inc. and Respcare, Inc. developed and marketed cutting edge sleep apnea therapy interfaces and masks. Competitors include: ResMed, Phillips Respironics, and Fisher & Paykel Healthcare Corporation Limited.

Mergenet Solutions, Inc. is still parent to Mergenet Medical, Inc. Mergenet Medical, Inc. is a developer of HIGH Flow Oxygen Therapy technology as well as other airway and airway secretion devices.

About Mergenet Solutions, Inc. Mergenet Solutions is an established American enterprise with worldwide reach.From an executive home base in Coconut Creek, Florida By functioning as a full-service technology incubator, our organization identifies, assists and invests in new and emerging companies in several promising sectors. Firms at the core of our existing portfolio are involved in cutting-edge advances in technology and breakthrough medical solutions.Learn more at www.mergenetsolutions.com

About Mergenet Medical Inc. (MMI): Mergenet Medical Inc is a global medical device company that designs and manufactures innovative medical devices that assist healthcare institutions measurably improve outcomes, reduce infections and improve patient and provider safety. Learn more atwww.mergenetmedical.com.

Contact: Elena HartmanisEMI Group 561.756.5551

View original content:http://www.prnewswire.com/news-releases/mergenet-solutions-inc-issues-dividend-300540463.html

SOURCE Mergenet Solutions, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store